| Literature DB >> 26993067 |
Agnes Klochendler1, Inbal Caspi2, Noa Corem1, Maya Moran3, Oriel Friedlich1, Sharona Elgavish4, Yuval Nevo4, Aharon Helman1, Benjamin Glaser5, Amir Eden3, Shalev Itzkovitz2, Yuval Dor6.
Abstract
The molecular program underlying infrequent replication of pancreatic β-cells remains largely inaccessible. Using transgenic mice expressing green fluorescent protein in cycling cells, we sorted live, replicating β-cells and determined their transcriptome. Replicating β-cells upregulate hundreds of proliferation-related genes, along with many novel putative cell cycle components. Strikingly, genes involved in β-cell functions, namely, glucose sensing and insulin secretion, were repressed. Further studies using single-molecule RNA in situ hybridization revealed that in fact, replicating β-cells double the amount of RNA for most genes, but this upregulation excludes genes involved in β-cell function. These data suggest that the quiescence-proliferation transition involves global amplification of gene expression, except for a subset of tissue-specific genes, which are "left behind" and whose relative mRNA amount decreases. Our work provides a unique resource for the study of replicating β-cells in vivo.Entities:
Mesh:
Year: 2016 PMID: 26993067 PMCID: PMC4915587 DOI: 10.2337/db16-0003
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461
Figure 1Ccnb1-GFP marks replicating cells and allows for FACS sorting of quiescent and replicating β-cells. A: qRT-PCR analysis of sorted unstained, TSQ-stained, and Tomato+ islet cells. Results were normalized to Actb. Pnlip and Ki67 expression levels are presented relative to the expression in unstained islets and GFP− sorted cells, respectively. B: GO enrichment analysis of upregulated genes (FDR ≤0.05) in replicating β-cells. Overrepresentation was computed using a statistical test based on hypergeometric distribution. Gene sets with a P value <0.01 and an FDR <0.05 were considered significant.
Top 30 genes upregulated in replicating β-cells, sorted from lowest FDR (Benjamini-Hochberg)
| Gene symbol | Gene description | log2(FC) | FDR |
|---|---|---|---|
| Top2a | Topoisomerase (DNA) II α | 7.4 | 3.254E-137 |
| Cdk1 | Cyclin-dependent kinase 1 | 7.4 | 5.773E-135 |
| Hmmr | Hyaluronan-mediated motility receptor (RHAMM) | 7.3 | 1.779E-125 |
| Pbk | PDZ-binding kinase | 6.9 | 3.012E-125 |
| Cenpf | Centromere protein F | 7.0 | 1.478E-123 |
| Iqgap3 | IQ motif containing GTPase-activating protein 3 | 8.3 | 1.26E-122 |
| Nusap1 | Nucleolar and spindle–associated protein 1 | 7.2 | 2.723E-122 |
| Arhgef39 | ρ Guanine nucleotide exchange factor (GEF) 39 | 8.2 | 1.213E-120 |
| Cdca3 | Cell division cycle–associated 3 | 6.8 | 4.879E-118 |
| Cdca8 | Cell division cycle–associated 8 | 7.0 | 4.879E-118 |
| Neil3 | Nei-like 3 ( | 7.6 | 6.64E-118 |
| Cdc20 | Cell division cycle 20 | 6.9 | 4.026E-117 |
| Aurkb | Aurora kinase B | 7.7 | 1.448E-116 |
| Plk1 | Polo-like kinase 1 | 7.7 | 1.447E-115 |
| Tpx2 | TPX2, microtubule-associated protein homolog ( | 6.7 | 5.782E-115 |
| Troap | Trophinin-associated protein | 8.0 | 2.113E-114 |
| Fam64a | Family with sequence similarity 64, member A | 7.3 | 8.469E-114 |
| Ckap2l | Cytoskeleton-associated protein 2–like | 6.7 | 1.681E-113 |
| Cenpa | Centromere protein A | 6.6 | 2.528E-113 |
| Cenpe | Centromere protein E | 6.9 | 5.374E-113 |
| Birc5 | Baculoviral IAP repeat-containing 5 | 6.7 | 2.244E-112 |
| Ccnb2 | Cyclin B2 | 6.5 | 9.707E-112 |
| Ska1 | Spindle and kinetochore–associated complex subunit 1 | 8.2 | 9.707E-112 |
| Ccna2 | Cyclin A2 | 6.5 | 1.469E-111 |
| Mxd3 | Max dimerization protein 3 | 7.2 | 2.387E-111 |
| Casc5 | Cancer susceptibility candidate 5 | 7.5 | 5.009E-108 |
| Aspm | Abnormal spindle–like, microcephaly associated (Drosophila) | 6.7 | 8.609E-106 |
| Ankle1 | Ankyrin repeat and LEM domain–containing 1 | 7.5 | 9.805E-106 |
| Kif23 | Kinesin family member 23 | 6.8 | 9.805E-106 |
| Shcbp1 | Shc SH2-domain–binding protein 1 | 6.9 | 8.241E-104 |
DESeq was used to normalize the counts and compute log twofold change [log2(FC)] and FDR.
Top 30 most significantly induced genes in replicating β-cells not previously annotated as cell cycle regulated and not present in cell cycle–related gene sets
| Gene name | Gene description | log2(FC) | FDR |
|---|---|---|---|
| Suppressor APC domain–containing 2 | 6.8 | 8.4E-102 | |
| D17H6S56E-5 | DNA segment, Chr17, human D6S56E5 | 5.4 | 2.37E-91 |
| Tcf19 | Transcription factor 19 | 5.2 | 6.63E-81 |
| 4930579G24Rik | RIKEN cDNA 4930579G24 | 5.6 | 2.97E-78 |
| BC030867 | cDNA sequence BC030867 | 7.2 | 6.79E-70 |
| Slc9a5 | Solute carrier family 9 (sodium/hydrogen exchanger), member 5 | 6.3 | 1.24E-59 |
| Mtfr2 | Mitochondrial fission regulator 2 | 5.9 | 1.61E-59 |
| Sez6 | Seizure-related gene 6 | 6.9 | 2.4E-59 |
| Tripartite motif–containing 59 | 4.3 | 2.11E-57 | |
| Pbx4 | Pre–B-cell leukemia homeobox 4 | 5.2 | 2.74E-55 |
| DEP domain–containing 1a | 6.6 | 2.62E-54 | |
| 4930427A07Rik | RIKEN cDNA 4930427A07 gene | 4.2 | 8.27E-53 |
| Coiled-coil domain–containing 18 | 6.7 | 8.68E-52 | |
| Ccdc34 | Coiled-coil domain–containing 34 | 3.9 | 1.71E-50 |
| Cyp39a1 | Cytochrome P450, family 39, subfamily a, polypeptide 1 | 4.0 | 4.44E-48 |
| Regulator of G-protein signaling 12 | 4.6 | 5.37E-47 | |
| Zfp367 | Zinc finger protein 367 | 3.5 | 3.44E-43 |
| 4930452B06Rik | RIKEN cDNA 4930452B06 gene | 5.2 | 3.43E-42 |
| 2700094K13Rik | RIKEN cDNA 2700094K13 gene | 3.3 | 5.08E-41 |
| Zgrf1 | Zinc finger, GRF-type–containing 1 | 3.9 | 1.46E-39 |
| Katnal2 | Katanin p60 subunit A-like 2 | 3.9 | 2.51E-37 |
| Serine (or cysteine) peptidase inhibitor, clade B, member 8 | 4.8 | 1.1E-35 | |
| Tbc1d31 | WD repeat domain 67 | 3.3 | 1.94E-35 |
| BC055324 | cDNA sequence BC055324 | 4.5 | 2.21E-33 |
| Ccdc77 | Coiled-coil domain–containing 77 | 3.0 | 7.38E-30 |
| Rgs3 | Regulator of G-protein signaling 3 | 3.2 | 3.04E-28 |
| Heatr7b1 | Maestro heat-like repeat family member 2A | 3.5 | 8.15E-27 |
| Dnph1 | 2'-deoxynucleoside 5′-phosphate N-hydrolase 1 | 4.2 | 3.6E-26 |
| Lrdd | Leucine-rich and death domain–containing | 3.3 | 4.54E-26 |
| Neuralized homolog lb (Drosophila) | 5.3 | 5.67E-26 |
List of 30 genes compiled from cell cycle–GO categories, Whitfield cell cycle, and Benporath cycling genes from MSigDB. Genes associated with cancer (candidate oncogenes, tumor suppressor genes, or genes highly expressed in cancer) appear in boldface type. DESeq was used to normalize counts, compute log twofold change [log2(FC)], and calculate FDR (Benjamini-Hochberg).
Figure 2Genes repressed in replicating β-cells are involved in β-cell function and maturation. A: GO analysis of genes downregulated in replicating β-cells. B: Significant overrepresentation of genes upregulated in development in genes repressed in replicating β-cells (FDR ≤0.05) and, conversely, of genes repressed in development in genes induced in replicating β-cells (FDR ≤0.05). C: Genes induced in maturation and repressed in replication are associated with β-cell function. Genes repressed in maturation and activated in replication are associated with cell cycle biological processes. Overrepresentation was computed using a statistical test based on hypergeometric distribution.
Genes involved in secretion, encoding for insulin granule proteins, and regulating GSIS and repressed in replicating β-cells
| Secretion genes | Insulin granule genes | Genes regulating GSIS | ||||||
|---|---|---|---|---|---|---|---|---|
| Gene | log2(FC) | FDR | Gene | log2(FC) | FDR | Gene | log2(FC) | FDR |
| Sec23b | −0.73 | 7.80E-03 | Rab3a | −0.83 | 1.38E-02 | Slc2a2 | −1.38 | 1.25E-08 |
| Uso1 | −1.19 | 1.4E-06 | Ctsd | −0.61 | 4.15E-02 | G6pc2 | −1.83 | 7.85E-15 |
| Trappc4 | −0.67 | 3.01E-02 | Cpn1 | −1.26 | 9.54E-03 | Idh1 | −1.92 | 1.50E-13 |
| Scamp1 | −1.10 | 1.78E-05 | Ctsl | −1.65 | 1.24E-11 | Slc25a1 | −0.69 | 2.10E-02 |
| Osbpl5 | −1.05 | 1.40E-03 | Scg5 | −1.06 | 8.27E-03 | Glud1 | −0.86 | 2.11E-03 |
| Syn2 | −0.90 | 1.65E-03 | Hspa5 | −0.61 | 3.05E-02 | Ucn3 | −0.67 | 2.23E-02 |
| Rab3a | −0.83 | 1.38E-02 | Tcn2 | −1.24 | 2.71E-06 | |||
| Mcfd2 | −0.94 | 9.96E-03 | Pcsk2 | −0.72 | 9.36E-03 | |||
| Tpd52 | −0.70 | 1.34E-02 | Sytl4 | −0.76 | 5.06E-03 | |||
| Rab3d | −0.93 | 7.59E-03 | Pdia3 | −0.66 | 1.86E-02 | |||
| Sytl4 | −0.76 | 5.06E-03 | Clu | −0.74 | 1.16E-02 | |||
| Arfgap3 | −0.74 | 8.03E-03 | Cpe | −0.82 | 1.99E-03 | |||
| Stx4a | −0.69 | 3.40E-02 | Aldoa | −2.83 | 1.46E-31 | |||
| Stxbp3a | −1.10 | 5.88E-05 | ||||||
| Blzf1 | −1.01 | 6.95F-04 | ||||||
| Srp54c | −0.94 | 2.62E-03 | ||||||
| Sec23a | −0.94 | 1.62E-03 | ||||||
| Sar1b | −0.83 | 2.66E-03 | ||||||
| Snap23 | −1.12 | 3.80E-05 | ||||||
| Copb2 | −0.95 | 2.40E-04 | ||||||
| Scg5 | −1.06 | 8.27E-03 | ||||||
| Unc13b | −0.64 | 3.77E-02 | ||||||
| Scfd1 | −1.09 | 1.65E-05 | ||||||
| Sar1a | −0.77 | 4.18E-03 | ||||||
| Gars | −0.61 | 3.21E-02 | ||||||
| Rab1 | −0.65 | 2.34E-02 | ||||||
| Cog1 | −0.63 | 3.09E-02 | ||||||
| Rab27a | −0.96 | 2.08E-04 | ||||||
| Myo6 | −0.59 | 4.56E-02 | ||||||
FDR (Benjamini-Hochberg) and log twofold change [log2(FC)] as calculated by DESeq after count normalization.
Figure 3Targets of Nkx6.1, Pdx1, and MafA are repressed in replicating β-cells. A: Genes repressed in replicating β-cells are significantly enriched for targets of the β-cell transcription factors. The overrepresentation significance was computed using a statistical test based on hypergeometric distribution. B: FACS histograms of islet cells immunostained for insulin, Ki67, and Nkx6.1 or Pdx1. Cells were gated on insulin+ β-cells. Controls represent cells immunostained with isotype control. wt, wild type.
Figure 4Quantification of RNA molecules by smRNA-FISH in quiescent (GFP−) and replicating (GFP+) β-cells. A: Representative image of smRNA-FISH for the detection and measurement of single mRNA molecules of Actb, Glut2, and Ki67, as indicated. Actb level is elevated in GFP+ (arrow) compared with GFP− cells (arrowhead) (267 vs. 156 transcripts, respectively), whereas Glut2 levels remain unchanged (60 vs. 61, respectively). Ki67 (marker for replicating cell) is expressed only in GFP+ cells. Scale bar is 10 μm. Image is a maximal projection of 12 optical sections spaced 0.3 μm. B: Quantification based on 15–20 optical sections spaced 0.3 μm in the Z direction. Mean numbers (with SEM) of RNA molecules per optical Z-section per cell (≥20 GFP+ and GFP− cells) for the five measured genes. Each dot represents measurements from a single cell. C: The ratios of Glut2/Actb and Glul/Actb transcripts were computed per cell. Statistical significance was assessed using the nonparametric Mann-Whitney test (B and C) (*P < 0.05, ***P < 0.0001). D: qRT-PCR analysis of the indicated mRNAs. Relative mRNA levels (±SE) were calculated after normalization to Actb (n = 3) (*P < 0.05, **P < 0.005, paired t test). NS, not significant.
Figure 5Metabolic changes in replicating β-cells. A: Glycolytic genes repressed in GFP+ (replicating β-cells). Graph shows the mean expression (±SE) in GFP+ β-cells relative to quiescent GFP− β-cells, as derived from the RNA-seq data. All GFP+ values represent significant fold changes compared with GFP− values, as computed by DESeq (FDR <0.05). B–E: Mitochondrial membrane potential (∆Ψm) measured by TMRE staining in dissociated islet cells after incubation in low (3 mmol/L) and high (16 mmol/L) glucose. TMRE intensity is shown for GFP− (B) and GFP+ (C) islet cells incubated at both glucose concentrations; TMRE staining is shown in GFP− and GFP+ islet cells after incubation in low (3 mmol/L) and high (16 mmol/L) glucose (D and E, respectively).